Skip to main content
ASCPT 2024 Annual Meeting Main banner
Back

Kim Brouwer, PharmD, PhD

Associate Dean for Research and Graduate Education UNC Eshelman School of Pharmacy
University of North Carolina at Chapel Hill

Kim Brouwer, PharmD, PhD, is a Kenan Distinguished Professor in the School of Pharmacy and Curriculum in Toxicology at the University of North Carolina at Chapel Hill, and Associate Dean for Research and Graduate Education, UNC Eshelman School of Pharmacy. She received her BS in Pharmacy from Oregon State University, and completed a PharmD/Residency, PhD in Pharmaceutical Sciences/Pharmacokinetics, and postdoctoral fellowship in Pharmacology at the University of Kentucky prior to joining the UNC faculty. Her research program, supported by NIH since 1991, focuses on hepatobiliary drug disposition, hepatic transport proteins, and novel approaches to predict drug disposition, drug-transporter interactions, and hepatotoxicity. She has dedicated her career to fostering the development of future generations of clinical and translational pharmacologists. Dr. Brouwer was the founding Director of the UNC Pharmacokinetics/Pharmacodynamics Fellowship Program, and is Co-PI of NIH-funded Postdoctoral T32 Training Programs in Adult and Pediatric Clinical Pharmacology. She has served as major advisor for 35 PhD students, mentored more than 70 clinical pharmacology fellows and postdoctoral scholars, and authored more than 250 publications. Dr. Brouwer is co-inventor of B-CLEAR® technology and a company co-founder. She is a member of the International Transporter Consortium Steering Committee, and has served as a member of the ASCPT Board of Directors and the NIH Pharmacology Study Section. She is an AAPS Fellow and has received many prestigious awards for her outstanding contributions as a leading academic researcher including the PhRMA Foundation Award in Excellence in Pharmaceutics, UNC Inventor of the Year, ACCP Distinguished Investigator Award, an honorary doctorate from the University of Eastern Finland, the AACP Volwiler Research Achievement Award, and the ASCPT-FDA Abrams Award.

Disclosure(s): Audentes Therapeutics: Consultant/Advisory Board (Ongoing); BioIVT: Employment (Ongoing), Other Financial or Material Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Certara UK Limited (Simcyp Division): Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Gilead Sciences Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Otsuka Pharmaceutical Development & Commercialization, Inc.: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Schrodinger: Consultant/Advisory Board (Ongoing)

Presentation(s):